Connecting oncology professionals with relevant clinical trials

Selected clinical trial

RUPISTAR: A Study in Patients With ESR1-Mutated ER-Positive, HER2-Negative Advanced Breast Cancer

Sponsor: Evexta Bio

Phase: 3

Disease: ER-positive, HER2-negative advanced or metastatic breast cancer

EU trial number: 2026-527387-33-00

Population: Adults with ER-positive, HER2-negative advanced or metastatic breast cancer harboring an ESR1 mutation.

Register Investigator Interest

Interested in offering this trial to suitable patients?